GlassScriptPhysician profile
Terri Passante
NPI 1619594496
$605.85
in general payments reported to CMS, 2019-2025
13 companies · $154 in 2025
The $154 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $137 · 2023: $105 · 2024: $210 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $186.58 | 2022-2024 | Slynd |
| Mayne Pharma Commercial LLC | $89.34 | 2024-2025 | |
| Exact Sciences Corporation | $70.89 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $44.59 | 2022-2023 | |
| Organon LLC | $41.32 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $39.61 | 2024 | Gardasil 9, Gardasil |
| Coopersurgical, INC. | $35.09 | 2024-2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $20.46 | 2025 | |
| Sage Therapeutics, LLC | $17.48 | 2025 | Zurzuvae |
| Mycovia Pharmaceuticals, INC. | $15.43 | 2023 | Vivjoa |
| Therapeuticsmd, INC. | $15.42 | 2022 | |
| Shield Therapeutics INC | $15.02 | 2025 | |
| Millicent US INC | $14.62 | 2025 | Femlyv, Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terri Passante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.